NASDAQ
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
Open
$2.90
Previous Close
$2.84
Day High
$2.92
Day Low
$2.57
52 Week High
$63.00
52 Week Low
$2.57
No price data available for this timeframe.